Mayo Clinic invests virtual care startup Lin Health in an $11M Series A round to expand chronic pain treatment programs.

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful CIPN (40.44% and 38.35%, respectively). HealthDay News — The pooled prevalence of chronic painful ...

People undergoing chemotherapy can experience considerable side effects, including nausea and vomiting, hair loss, mood changes and other health issues. New research shows 4 in 10 people who have ...

DEAR MAYO CLINIC: My spouse suffers from chronic pain after a back injury five years ago. The pain affects his ability to work and enjoy day-to-day activities with our family. Seeing him in pain and ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might experience loss of balance and coordination, ...

Please provide your email address to receive an email when new articles are posted on . The odds of developing dry eye disease were nearly four-times higher in patients with moderate to severe ...

Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors Acute and chronic neuropathy was evaluated in patients receiving adjuvant FOLFOX ...

One cause of a sudden loss of vision is referred to in medical terms as ischemic optic neuropathy. There are two types. One is caused by inflamed arteries in the eye that flow to the optic nerve, and ...

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence. (HealthDay News) — The pooled prevalence of chronic painful ...